Dutch Bros Inc. (BROS)
NYSEConsumer DiscretionaryRestaurantsSnapshot 2026-11-04
$43.99+0.94%
Close 2026-11-04 · 1-day change
NYSEConsumer DiscretionaryRestaurantsSnapshot 2026-11-04
Research Workspace
Put BROS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Restaurants is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 30% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 45%, softest on share dilution.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 49% in its worst 12-month stretch.
View RiskBROS needs same-shop sales growth of 5% to 6% to justify its price. Revenue grew 29.8% year over year in the latest quarter. The company beat earnings expectations by 13.6% in Q3. It trades at 51 times earnings versus a 17 times peer median. The price reflects less growth than our forecast. Slowing sales threaten the 5% to 6% growth target. Peer multiples imply a price about 16% below where it trades. Our read remains intact. This read is provisional.
Trailing returns as of 2026-11-04. BROS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 26 analysts currently covering BROS (as of Nov 2026).
Based on 10 Wall Street analysts offering 12-month price targets for BROS in the last 4 months.
Continue this research
Compare BROS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BROS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Restaurants — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put BROS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Cautious outlook directly challenges growth and EBITDA targets.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $43.99
The last 12 months of price, then the range of analyst 12-month targets from today’s $43.99.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Achieve Adjusted EBITDA of approximately $380M
Margin pressure threatens EBITDA target.
Threatens: Achieve Adjusted EBITDA of approximately $380M
Guidance cut signals lower EBITDA outlook.
Threatens: Drive 30% revenue growth and expand total system shop openings
Unit growth concerns threaten expansion goals.
Advances: Drive 30% revenue growth and expand total system shop openings
Confirms aggressive growth targets and expansion plans.
Large insider sale by executive chairman signals potential loss of confidence.
Threatens: Drive same shop sales growth of 5%-6% in 2026
Slowing sales and cut EBITDA outlook directly threaten growth targets.
Threatens: Drive same shop sales growth of 5%-6% in 2026
Stock tumble signals market concern over slowing sales performance.
